Reports Search Total = 3

Netherlands Floriculture Market – Growth, Trends, and Forecast (2019 – 2024)

Agriculture Published by: Mordor Intelligence Market: Netherlands
60 pages Published: 23-07-2019
  • Agriculture
  • Mordor Intelligence
  • Netherlands
  • 60 pages
  • Published: 23-07-2019

Market Overview

 

The Netherlands floriculture market was valued at USD 3,922.5 million in 2018 and is expected to register a CAGR of 6.3% during the forecast period (2019-2024). Among the cut flowers, Rosa accounted for the major share of 31.3%, followed by Chrysanthemum with 11.5%, in 2018.

 

The Netherlands had to deal with a loss of approximately 320 bulb growing companies between 2006 and 2016, which affected the development of competition in the form of other emerging markets. The rise of developing countries as flower growers is a challenge for the flower growing market in the Netherlands, as well as the local economy.

 

Scope of the Report

 

Floriculture is a type of horticulture practice, which focuses on the cultivation of flowering and ornamental plants for gardens, as well as for commercial use.  The report presents an in-depth analysis of the market size and trade analysis of different types of flowers popular in the Netherlands floriculture market, and a detailed analysis of flower farming and flower farms in the Netherlands.

 

Key Market Trends

 

The Fastest-growing Segment by Flower Type – Cut Flowers, Flower Bulbs and Plants

 

The increasing number of flower cultivators in developing countries and the shift of wholesalers to these countries act as challenges for the floriculture market in the Netherlands. However, developments in e-commerce are likely to have a positive impact on the floriculture market in the Netherlands, with the opportunity to complete direct sales with the consumers, instead of using an intermediary. The logistical position of the country within Europe and the established international trade links within the flower industry make Europe the core of the flower market in the Netherlands. Countries, like Ecuador, Colombia, Kenya, and Ethiopia, are the leading suppliers of live trees, plants, and flowers to the Netherlands. Kenya is the second-largest importer of flowers in the Netherlands.

 

Growing Export Potential for Floral Products

 

The Netherlands is the largest exporter of cut flowers around the world. The export value of fresh cut flowers was valued at more than USD 8,639 million in 2017. The flower market in the Netherlands is a dynamic, fast-growing global industry, defined by three major components, growers, wholesalers, and retailers. The Netherlands is the largest producer for cut flowers, as well as a key importer from developing countries. Apart from being one of the market leaders for cut flowers, the Netherlands is also the main trade hub, especially in the area of Aalsmeer. The major importers of cut flowers from the Netherlands are Germany, the United Kingdom, France, and Belgium, importing by value USD 1,207 million, USD 605 million, USD 527 million, and USD 172 million, respectively.

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Introduction to Market Drivers and Restraints

4.3 Market Drivers

4.4 Market Restraints

4.5 Industry Attractiveness – Porter’s Five Force Analysis

4.5.1 Threat of New Entrants

4.5.2 Bargaining Power of Buyers/Consumers

4.5.3 Bargaining Power of Suppliers

4.5.4 Threat of Substitute Products

4.5.5 Intensity of Competitive Rivalry 

4.6 Country Profile

4.6.1 PESTLE Analysis

4.6.2 Business Opportunities

5 MARKET SEGMENTATION

5.1 Type of Flower

5.1.1 Rosa

5.1.2 Tulipa

5.1.3 Chrysanthemum

5.1.4 Gerbera

5.1.5 Freesia

5.1.6 Lily

5.1.7 Orchids

5.1.8 Nursery Stocks

5.1.9 Others

6 VALUE CHAIN & TRADE ANALYSIS

6.1 Value Chain Analysis

6.2 Distribution Channel Analysis

6.3 Trade Analysis

6.3.1 Import Analysis

6.3.2 Export Analysis

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

Type of Flower

Rosa

Tulipa

Chrysanthemum

Gerbera

Freesia

Lily

Orchids

Nursery Stocks

Others

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Netherlands Aesthetic Devices Market- Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Netherlands
65 pages Published: 23-07-2019
  • Healthcare
  • Mordor Intelligence
  • Netherlands
  • 65 pages
  • Published: 23-07-2019

Market Overview

 

The propelling factors for the growth of the Netherlands aesthetic devices market include the continuous technological advancements, rising adoption of minimally invasive devices, and increasingly obese population.

 

In recent years, the number of cosmetic surgeries has increased considerably. The rapid rise in the number of surgeries performed each day is among the primary factors increasing the demand for aesthetic devices in the Netherlands. In addition, medical aesthetic technology has advanced and reached the end user rapidly over the last two decades. The continuous improvement in the distribution channel and feasibility in hospitals and clinics with advanced technologies have offered a wide range of products and solutions to patients seeking medical assistance.

 

Scope of the Report

 

As per the scope of the report, aesthetic devices are the medical devices that are used for various cosmetic procedures, which include plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, etc., that are used for the beautification, correction, and improvement of the body. Therefore, medical aesthetics focus on improving cosmetic appearance by using these devices.

 

Key Market Trends

 

Breast Implants is Estimated to Procure Largest Share in this Market, over the Forecast Period

 

Breast implants are the most common and popular aesthetic surgery procedure in developed markets. There is also a demand for breast enhancement and high incidence of breast cancer among the population and there is an increase in awareness about beauty and physical appearance. Thus, all these factors are expected to increase the overall growth of the market. There are a large number of hospitals and cosmetic centers which are specially designed for the population requiring breast implants across the Netherlands. The awareness levels and its importance among the female population plays a significant role in driving the breast implants segmentation rise in the Netherlands.

 

Competitive Landscape

 

The companies dealing in the medical aesthetics market have been leveraging mergers and acquisitions, internal R&D and new partnership to expand their business in other regions, especially in the promising emerging market.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increase In Number Of Cosmetic Surgeries

4.2.2 Continuous Technological Advancements

4.2.3 Rising Adoption of Minimally Invasive Devices

4.3 Market Restraints

4.3.1 Poor Reimbursement Scenario

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Type of Device

5.1.1 Energy Based Aesthetic Device

5.1.1.1 Laser Based Aesthetic Device

5.1.1.2 Radiofrequency (RF) Based Aesthetic Device

5.1.1.3 Light Based Aesthetic Device

5.1.1.4 Ultrasound Aesthetic Device

5.1.2 Non Energy Based Aesthetic Device

5.1.2.1 Botulinum Toxin

5.1.2.2 Dermal Fillers and Aesthetic Threads

5.1.2.3 Chemical Peels

5.1.2.4 Microdermabrasion

5.1.2.5 Implants

5.1.2.5.1 Facial Implants

5.1.2.5.2 Breast Implants

5.1.2.5.3 Other Impalnts

5.1.2.6 Other Aesthetic devices

5.2 By Application

5.2.1 Skin Resurfacing and Tightening

5.2.2 Body Contouring and Cellulite Reduction

5.2.3 Hair Removal

5.2.4 Tattoo removal

5.2.5 Breast Augmentation

5.2.6 Other Applications

5.3 By End Users

5.3.1 Hospitals

5.3.2 Clinics

5.3.3 Home Settings

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Allergan, Inc.

6.1.2 Alma Lasers

6.1.3 Entercare

6.1.4 Johnson & Johnson

6.1.5 Lumenis, Inc.

6.1.6 Galderma S.A. (Nestle)

6.1.7 Sciton Inc.

6.1.8 List Not Exhaustive

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Type of Device

Energy Based Aesthetic Device

Laser Based Aesthetic Device

Radiofrequency (RF) Based Aesthetic Device

Light Based Aesthetic Device

Ultrasound Aesthetic Device

Non Energy Based Aesthetic Device

Botulinum Toxin

Dermal Fillers and Aesthetic Threads

Chemical Peels

Microdermabrasion

Implants

Facial Implants

Breast Implants

Other Impalnts

Other Aesthetic devices

 

By Application

Skin Resurfacing and Tightening

Body Contouring and Cellulite Reduction

Hair Removal

Tattoo removal

Breast Augmentation

Other Applications

 

By End Users

Hospitals

Clinics

Home Settings

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Netherlands In-Vitro Diagnostics Market – Growth, Trends & Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Netherlands
75 pages Published: 07-06-2019
  • Healthcare
  • Mordor Intelligence
  • Netherlands
  • 75 pages
  • Published: 07-06-2019

Market Overview

The Netherlands in vitro diagnostics market is expected to register a CAGR of approximately 5.3% over the forecast period. Major factors that are fueling this market include rapid increase in chronic diseases, increasing demand for point-of-care testing and personalized medicine, and technological advances, along with the rising geriatric population in the country.

As per a report of National Institute of Health (NIH), incidences and prevalence of chronic diseases are rapidly increasing across the world and are currently affecting more than 14 million people around the world. Furthermore, according to the World Health Organization, the prevalence rate of the overweight population in the Netherlands was 67% for men and 59% for women in 2016, and this rate is expected to increase in the coming years. 

According to the European Diagnostic Manufacturers Association (EDMA), the cost of IVDs to the European healthcare systems is less than EUR 21 per person per year. In addition, patients can deal with their conditions better with the help of IVDs (diabetic patients can use portable blood glucose monitors on a regular basis to determine their blood glucose level). Therefore, the demand for IVD products is influenced by the increase in incidences of chronic diseases. As the demand for IVD is increasing, the market is growing at a faster pace.

Scope of the Report

IVDs are tests performed in laboratories or by consumers at homes, to diagnose, monitor, screen, and assess various diseases, conditions, or infections. IVD products are reagents, instruments, and systems that are intended for use in the diagnosis of diseases or other conditions. IVDs form an essential part of the current healthcare system. They reduce hospital stays and the need to recuperate.

Key Market Trends

The Point-Of-Care Diagnostics Segment is Expected to Experience the Highest CAGR Over the Forecast Period

The point-of-care (PoC) diagnostics segment of the Netherlands in vitro diagnostics market is expected to register the highest CAGR during the forecast period.

There is a significant demand for PoC diagnostics that can provide accurate and directional results. These PoC tests allow healthcare providers to begin essential treatment during visits. Many nucleic acids and immunoassay-based PoC diagnostic devices are coming close to commercialization.

Earlier, the lack of an efficient reimbursement system for the PoC technology led to the absence of both niche markets and entrepreneurial activities by large manufacturers. Hence, the Dutch government has now actively stimulated the primary diagnostic system by implementing new guidelines and lobbies. This triggered consolidation processes, entrepreneurial activities, the diagnostic market, and the performance of the IVD innovation system.

Hence, owing to the support of the government, along with the significance of PoC, the segment is expected to experience growth faster.

Competitive Landscape

The Netherlands in vitro diagnostics market has several key players, such as Roche Diagnostics, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, and Thermo Fisher Scientific Inc., who hold large shares in this market. However, with the help of product innovation and technological advances, there is a possibility of new players entering the market in the future. 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rapid Increase in Chronic Diseases

4.2.2 Increasing Number of Private Hospitals and Independent Testing Laboratories

4.2.3 Increasing Demand for Point-of-Care Testing and Personalized Medicine

4.2.4 Technological Advances along with Rising Geriatric Population

4.3 Market Restraints

4.3.1 Price Concern

4.3.2 Stringent Regulatory Framework

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Technology

5.1.1 Clinical Chemistry

5.1.2 Immunoassays

5.1.3 Hematology

5.1.4 Coagulation and Hemostasis

5.1.5 Microbiology

5.1.6 Point-of-Care Diagnostics

5.1.7 Molecular Diagnostics

5.2 By Product

5.2.1 Instrument

5.2.2 Reagent

5.2.3 Data Management Systems and Services

5.3 By Usability

5.3.1 Disposable IVD Devices

5.3.2 Reusable IVD Devices

5.4 By End User

5.4.1 Hospitals and Clinics

5.4.2 Laboratories

5.4.3 Academics

5.4.4 Point-of-Care Testing

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abbott Laboratories

6.1.2 Becton, Dickinson and Company

6.1.3 Bio-Rad Laboratories Inc.

6.1.4 Danaher Corporation

6.1.5 Johnson & Johnson

6.1.6 Roche Diagnostics

6.1.7 Siemens Healthcare

6.1.8 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Technology

Clinical Chemistry

Immunoassays

Hematology

Coagulation and Hemostasis

Microbiology

Point-of-Care Diagnostics

Molecular Diagnostics

 

By Product

Instrument

Reagent

Data Management Systems and Services

By Usability

Disposable IVD Devices

Reusable IVD Devices

By End User

Hospitals and Clinics

Laboratories

Academics

Point-of-Care Testing

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type